Event | Economic and Healthcare Spending

Nov 2021

On 6 November 2021, the Lincoln International Healthcare team hosted a C-Suite focused evening at Dartmouth House in Mayfair, co-sponsored by CIL Consulting and Global Counsel, with guest speakers David Smith, Economics Editor of the Sunday Times, and Matthew Swindells, the former Deputy CEO of NHS England.

Key highlights included:

  • A critique of both Conservative and Labour policies in the run up to the election, including opinions on outsourcing to the private sector
  • Concern over the impact of Brexit on various areas of healthcare, including staff recruitment and retention
  • NHS spending will increase regardless of who wins the election, but it may need to increase further to meet the demands placed upon it

Click here to view a snapshot of remarks from our speakers.

Click here to download presentation slides.

View the full recording of the presentation below:

Contributor

Meet Professionals with Complementary Expertise

Related Perspectives

PETS International | Consolidation Meets Regulation in the Veterinary Clinics Market

Originally posted by PETS International on April 5, 2024. Animal health is becoming a big business in Europe and the U.S. Thus, regulators are turning a closer eye to mergers… Read More

“Leader to Leader” Series

The Leader to Leader video series turns up the dial on rich conversations with prominent leaders – from business owners and entrepreneurs to investors and CEOs – highlighting their stories… Read More

What Price is Right? Trends and Opportunities for Private Equity in Pharma Market Access

The cost of developing new drugs is staggering. Among the top 20 global biopharmas, the average cost of developing a candidate from discovery through clinical trials to market was approximately… Read More

Investment Opportunities in Pharma: A Data-Driven Exploration of CDMO Appeal

The report discusses the current state of the contract development and manufacturing organization (CDMO) market within the pharmaceutical industry, emphasizing the increased interest from private equity (PE) investors. The pharmaceutical… Read More